1. Home
  2. BCYC vs LYTS Comparison

BCYC vs LYTS Comparison

Compare BCYC & LYTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCYC
  • LYTS
  • Stock Information
  • Founded
  • BCYC 2009
  • LYTS 1976
  • Country
  • BCYC United Kingdom
  • LYTS United States
  • Employees
  • BCYC N/A
  • LYTS N/A
  • Industry
  • BCYC Biotechnology: Pharmaceutical Preparations
  • LYTS Building Products
  • Sector
  • BCYC Health Care
  • LYTS Consumer Discretionary
  • Exchange
  • BCYC Nasdaq
  • LYTS Nasdaq
  • Market Cap
  • BCYC 566.5M
  • LYTS 518.5M
  • IPO Year
  • BCYC 2019
  • LYTS N/A
  • Fundamental
  • Price
  • BCYC $8.22
  • LYTS $16.27
  • Analyst Decision
  • BCYC Buy
  • LYTS Strong Buy
  • Analyst Count
  • BCYC 10
  • LYTS 2
  • Target Price
  • BCYC $25.00
  • LYTS $26.00
  • AVG Volume (30 Days)
  • BCYC 333.0K
  • LYTS 108.8K
  • Earning Date
  • BCYC 05-01-2025
  • LYTS 04-24-2025
  • Dividend Yield
  • BCYC N/A
  • LYTS 1.23%
  • EPS Growth
  • BCYC N/A
  • LYTS N/A
  • EPS
  • BCYC N/A
  • LYTS 0.72
  • Revenue
  • BCYC $25,722,000.00
  • LYTS $547,316,000.00
  • Revenue This Year
  • BCYC N/A
  • LYTS $21.02
  • Revenue Next Year
  • BCYC $1.83
  • LYTS $7.32
  • P/E Ratio
  • BCYC N/A
  • LYTS $22.60
  • Revenue Growth
  • BCYC N/A
  • LYTS 17.89
  • 52 Week Low
  • BCYC $6.10
  • LYTS $13.63
  • 52 Week High
  • BCYC $28.67
  • LYTS $25.50
  • Technical
  • Relative Strength Index (RSI)
  • BCYC 49.16
  • LYTS 52.86
  • Support Level
  • BCYC $8.00
  • LYTS $15.31
  • Resistance Level
  • BCYC $8.73
  • LYTS $16.45
  • Average True Range (ATR)
  • BCYC 0.48
  • LYTS 0.37
  • MACD
  • BCYC 0.02
  • LYTS 0.04
  • Stochastic Oscillator
  • BCYC 33.33
  • LYTS 53.93

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.

About LYTS LSI Industries Inc.

LSI Industries Inc provides corporate visual image solutions to the petroleum and convenience store industry. The company's operating segments include Lighting and Display Solutions. It generates maximum revenue from the Lighting segment. Lighting Segment manufactures and markets outdoor and indoor lighting and lighting controls for the commercial, industrial, and multi-site retail markets including the petroleum/convenience store, quick-service, and automotive markets. The Display Solutions Segment manufactures, sells and installs exterior and interior visual image and display elements, including printed graphics, structural graphics, digital signage, menu board systems, display fixtures, refrigerated displays and custom display elements.

Share on Social Networks: